![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 5
2022
Heppt, Markus V.; Wessely, Anja; Hornig, Eva; Kammerbauer, Claudia; Graf, Saskia A.; Besch, Robert; French, Lars E.; Matthies, Alexander; Kuphal, Silke; Kappelmann-Fenzl, Melanie; Bosserhoff, Anja K. und Berking, Carola
(2022):
HDAC2 Is Involved in the Regulation of BRN3A in Melanocytes and Melanoma.
In: International Journal of Molecular Sciences, Bd. 23, Nr. 2, 849
2018
Heppt, Markus V.; Wang, Joshua X.; Hristova, Denitsa M.; Wei, Zhi; Li, Ling; Evans, Brianna; Beqiri, Marilda; Zaman, Samir; Zhang, Jie; Irmler, Martin; Berking, Carola; Besch, Robert; Beckers, Johannes; Rauscher, Frank J.; Sturm, Rick A.; Fisher, David E.; Herlyn, Meenhard und Fukunaga-Kalabis, Mizuho
(2018):
MSX1-Induced Neural Crest-Like Reprogramming Promotes Melanoma Progression.
In: Journal of Investigative Dermatology, Bd. 138, Nr. 1: S. 141-149
2016
Matheis, Fanny; Heppt, Markus V.; Graf, Saskia A.; Düwell, Peter; Kammerbauer, Claudia; Aigner, Achim; Besch, Robert und Berking, Carola
(2016):
A Bifunctional Approach of Immunostimulation and uPAR Inhibition Shows Potent Antitumor Activity in Melanoma.
In: Journal of investigative Dermatology, Bd. 136, Nr. 12: S. 2475-2484
2012
Senft, Daniela; Berking, Carola; Graf, Saskia A.; Kammerbauer, Claudia; Ruzicka, Thomas und Besch, Robert
(2012):
Selective induction of cell death in melanoma cell lines through targeting of Mcl-1 and A1.
In: PLOS ONE 7(1), e30821 [PDF, 1MB]
In: PLOS ONE 7(1), e30821 [PDF, 1MB]
2010
Zall, Henry; Weber, Arnim; Besch, Robert; Zantl, Niko und Haecker, Georg
(2010):
Chemotherapeutic drugs sensitize human renal cell carcinoma cells to ABT-737 by a mechanism involving the Noxa-dependent inactivation of Mcl-1 or A1.
In: Molecular Cancer
9:164
[PDF, 1MB]